This HTML5 document contains 156 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
wdthttp://www.wikidata.org/prop/direct/
wdtnhttp://www.wikidata.org/prop/direct-normalized/
schemahttp://schema.org/
skoshttp://www.w3.org/2004/02/skos/core#
rdfshttp://www.w3.org/2000/01/rdf-schema#
n8http://dx.doi.org/10.1186/
wikibasehttp://wikiba.se/ontology#
phttp://www.wikidata.org/prop/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
n12http://rdf.ncbi.nlm.nih.gov/pubchem/reference/
xsdhhttp://www.w3.org/2001/XMLSchema#
wdshttp://www.wikidata.org/entity/statement/
n6https://scigraph.springernature.com/pub.10.1186/
wdhttp://www.wikidata.org/entity/

Statements

Subject Item
wd:Q37554951
rdf:type
wikibase:Item
schema:description
vedecký článok vědecký článek bilimsel makale artículu científicu espublizáu en 2017 مقالة علمية نشرت في 03 يناير 2017 videnskabelig artikel vetenskaplig artikel scientific article published on 03 January 2017 wetenschappelijk artikel наукова стаття, опублікована в січні 2017 article científic artigo científico wissenschaftlicher Artikel научни чланак article scientifique articolo scientifico
p:P577
wds:Q37554951-52296BA0-3BAB-4113-92D6-08D01C93390D
wdt:P577
2017-01-03T00:00:00Z
p:P2888
wds:Q37554951-CAB4F8F5-6209-4FAD-831A-BAADF0F42EF7
wdt:P2888
n6:s12967-016-1107-2
p:P2860
wds:Q37554951-A03729E0-2B98-4D3B-8D4F-D28ABF44475E wds:Q37554951-A064985B-2B9D-4D36-AD6D-396A9D69B2A8 wds:Q37554951-A342FC5B-8862-4AC4-A71D-9B956F8D3BF6 wds:Q37554951-DC96424E-D75F-429A-A56F-4593F5B144CF wds:Q37554951-E1B9F1D1-434C-43E2-A834-6E112883CB2E wds:Q37554951-C62363E4-4B7F-4F04-A4AC-2B81D27C37F4 wds:Q37554951-CAE5C331-3AE8-4122-AE10-CC170E794B06 wds:Q37554951-CCD20832-24C7-42EC-893A-17F247A7B9CD wds:Q37554951-65C5CDD3-F846-433E-9BA5-E86EBEE00F23 wds:Q37554951-70C3709A-9F9A-44D5-995A-4810757E7A79 wds:Q37554951-5A1F3399-D188-4546-9DC0-A43C0FCD0637 wds:Q37554951-642521EE-BF28-4B55-8310-833313A0A843 wds:Q37554951-87232BC3-47EF-4C77-B8B6-819697FD7303 wds:Q37554951-872A5C6D-74BD-4D3A-B416-33361800ABD5 wds:Q37554951-9756A9C2-EFAE-4B21-A7E3-30EAB28BCD71 wds:Q37554951-7D49DA72-15FA-4CF6-9EEF-652EB1495D1E wds:Q37554951-83931891-5F6E-4CEF-9A33-777A45E5956A wds:Q37554951-30F6BA4D-6681-4260-90E5-3F28778B8264 wds:Q37554951-3581E1A3-D7D9-4BD5-9491-56B4CAAE271D wds:Q37554951-397AE2AD-D27D-4F1B-A846-AE64BEFED0C4 wds:Q37554951-22F42543-6164-4878-BC40-8D532EE8ED70 wds:Q37554951-23B18CF8-9910-4277-BE72-045F96FA0098 wds:Q37554951-4983277D-697F-4144-9083-4BAF87C128EF wds:Q37554951-4BC4D6C3-55E1-41DF-9E81-D4917718D452 wds:Q37554951-4C6BCCCB-404D-4EBC-BD8D-C99AD3724964 wds:Q37554951-3F32236A-D42C-471F-9002-4FE77183DC61 wds:Q37554951-10C47C15-3D9B-439B-8FCB-C4F24ABD22A8 wds:Q37554951-1CF74907-F324-4CD4-8316-467B1F422D71 wds:Q37554951-0A783A6F-7CF4-4E46-83CC-C186B75756F4 wds:Q37554951-F1A6D152-045A-48FC-897C-DB1D4212C762 wds:Q37554951-F59D1BFD-1A10-40F3-8DE3-87D20E5B4ACA wds:Q37554951-FD440CE6-E8FE-4E42-89F7-C665CC9E7A46 wds:Q37554951-E48903DE-DB41-4D6D-8103-1B0B0D2A9E90 wds:Q37554951-E8D2502D-C43C-46B4-85F3-1244A57460D8 wds:Q37554951-A78D5B85-8C15-46E3-A745-5B0A42E2F08E wds:Q37554951-B5065520-7A8A-4D2F-82B7-724E8835A50E wds:Q37554951-BCA9C2CA-D8A1-41D0-96CD-4A36315E3025
wdt:P2860
wd:Q71654478 wd:Q34772401 wd:Q28080830 wd:Q36862313 wd:Q36761427 wd:Q44847236 wd:Q37023497 wd:Q37397999 wd:Q24642481 wd:Q35849351 wd:Q51621225 wd:Q27012881 wd:Q73309708 wd:Q34412254 wd:Q34975536 wd:Q50463607 wd:Q35024781 wd:Q73235487 wd:Q36445393 wd:Q37060673 wd:Q34162925 wd:Q37276359 wd:Q77292395 wd:Q50506365 wd:Q50554968 wd:Q54327926 wd:Q77304817 wd:Q53337615 wd:Q35679682 wd:Q37354296 wd:Q42767299 wd:Q73756641 wd:Q50085668 wd:Q47992512 wd:Q75204524 wd:Q44826022 wd:Q35730965
p:P2093
wds:Q37554951-01627938-2B10-4C30-AB24-4BA5E492EC29 wds:Q37554951-0650E311-2017-41E4-92E5-75527B776CCE wds:Q37554951-0201540F-CC54-4DC7-88BD-6CFB83D24F9D wds:Q37554951-1734C9AE-AC10-4032-AF49-91535807CCEC wds:Q37554951-26BE8CFB-3BBF-46D9-AB51-FA095F32444F wds:Q37554951-210E10E8-C586-4AF0-B49F-EBFFDD8A2767 wds:Q37554951-41FBE076-820C-4603-8A5F-4CEF460E77B2 wds:Q37554951-46E9860E-3EBF-45AB-9BCB-A1B8C8058348 wds:Q37554951-3DDCB3C2-F94D-4670-BDD8-BEE91ECFA22E wds:Q37554951-767B2475-841E-4E5F-8AC3-6A0259ECC51A wds:Q37554951-4813DA84-EFFC-483E-AAA0-58CEAAE56945 wds:Q37554951-7BB17008-6595-4FE7-9786-947A07048DCB wds:Q37554951-DB573D7A-346D-4AAA-B8FB-48A4C144BD0D wds:Q37554951-E5C6BB2C-9E2D-4C22-AEE9-C15892A4C2C3 wds:Q37554951-E38DD1A2-D47D-41DE-8E60-2C0147DEF399
wdt:P2093
Darja Karpova Leon Hooftman Hans Martin Eliza Wiercinska Christophe Escot Garry Douglas Achim Wach Halvard Bonig Susanne Bräuninger Ariane Krämer Belinda Stock Jochen Graff Eric Chevalier Klaus Dembowski Barbara Romagnoli
rdfs:label
Mobilization of hematopoietic stem cells with the novel CXCR4 antagonist POL6326 (balixafortide) in healthy volunteers-results of a dose escalation trial Mobilization of hematopoietic stem cells with the novel CXCR4 antagonist POL6326 Mobilization of hematopoietic stem cells with the novel CXCR4 antagonist POL6326 (balixafortide) in healthy volunteers-results of a dose escalation trial
skos:prefLabel
Mobilization of hematopoietic stem cells with the novel CXCR4 antagonist POL6326 (balixafortide) in healthy volunteers-results of a dose escalation trial Mobilization of hematopoietic stem cells with the novel CXCR4 antagonist POL6326 (balixafortide) in healthy volunteers-results of a dose escalation trial Mobilization of hematopoietic stem cells with the novel CXCR4 antagonist POL6326
schema:name
Mobilization of hematopoietic stem cells with the novel CXCR4 antagonist POL6326 (balixafortide) in healthy volunteers-results of a dose escalation trial Mobilization of hematopoietic stem cells with the novel CXCR4 antagonist POL6326 Mobilization of hematopoietic stem cells with the novel CXCR4 antagonist POL6326 (balixafortide) in healthy volunteers-results of a dose escalation trial
p:P1476
wds:Q37554951-DFD694EB-3AE4-48ED-9C98-70B167503887
wdt:P1476
Mobilization of hematopoietic stem cells with the novel CXCR4 antagonist POL6326 (balixafortide) in healthy volunteers-results of a dose escalation trial
p:P304
wds:Q37554951-2EB95C50-3498-4E7E-BF9E-9EA84FDEAF42
wdt:P304
2
p:P31
wds:Q37554951-6D8C2418-0316-4713-B3B8-773A52D64B71
wdt:P31
wd:Q13442814
p:P698
wds:Q37554951-A579264A-3C93-4A91-BB4D-F356DF2D1636
wdtn:P698
n12:28049490
wdt:P698
28049490
p:P1433
wds:Q37554951-9DDF5CCA-737B-4C53-9693-0363D0C9D951
wdt:P1433
wd:Q15716664
p:P433
wds:Q37554951-0FD3AFD6-D82D-4FA5-8BF0-796C494F2563
p:P478
wds:Q37554951-7B41C803-F7D9-40D5-B014-3720FF406A12
wdt:P433
1
wdt:P478
15
p:P356
wds:Q37554951-57AD453D-3D22-4EBC-A580-BC37A3550C9C
wdtn:P356
n8:S12967-016-1107-2
wdt:P356
10.1186/S12967-016-1107-2
p:P6179
wds:Q37554951-98F44385-B8F7-4FF7-BF7C-1BA64223A40C
wdt:P6179
1050310479
p:P932
wds:Q37554951-03122119-D584-48DF-88E2-CAAD799B5B66
wdt:P932
5209880